Form 4 Tracker
ROCKET PHARMACEUTICALS, INC.
RCKT

31 insider filings · Latest: Aug 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 13, 2026May 13 7:10 PMMilitello John
Proposed Sale
855$3.61$3.1K

View →

May 7, 2026May 11 11:48 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Sale
17,650$3.84$67.7K267,510(D)

View →

May 7, 2026May 7 7:14 PMChaudhuri Sarbani
Proposed Sale
17,650$3.84$67.7K

View →

Feb 18, 2026Feb 20 9:31 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
1,157$3.34$3.9K91,019(D)

View →

Feb 18, 2026Feb 20 9:26 PMGaurav ShahCEO
Sale
5,990$3.34$20.0K1,046,055(D)

View →

Feb 18, 2026Feb 20 9:09 PMMartin WilsonGeneral Counsel
Sale
1,376$3.34$4.6K682,000(D)

View →

Feb 13, 2026Feb 18 10:42 PMMartin WilsonGeneral Counsel
Sale
12,253$3.31$40.6K683,376(D)

View →

Feb 13, 2026Feb 18 10:38 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Sale
3,726$3.31$12.3K92,176(D)

View →

Feb 13, 2026Feb 18 10:33 PMGaurav ShahCEO
Sale
12,279$3.31$40.7K1,052,045(D)

View →

Feb 18, 2026Feb 18 9:58 PMMilitello John
Proposed Sale
1,157$3.34$3.9K

View →

Feb 18, 2026Feb 18 9:50 PMWilson Martin
Proposed Sale
1,376$3.34$4.6K

View →

Feb 18, 2026Feb 18 9:50 PMShah Gaurav
Proposed Sale
5,990$3.34$20.0K

View →

Feb 13, 2026Feb 13 9:31 PMWilson Martin
Proposed Sale
12,253$3.31$40.6K

View →

Feb 13, 2026Feb 13 8:55 PMShah Gaurav
Proposed Sale
12,279$3.31$40.7K

View →

Feb 13, 2026Feb 13 8:53 PMSchwartz Jonathan David
Proposed Sale
14,508$3.31$48.1K

View →

Feb 13, 2026Feb 13 8:39 PMMilitello John
Proposed Sale
3,726$3.31$12.3K

View →

Nov 18, 2025Nov 18 8:57 PMSchwartz Jonathan David
Proposed Sale
2,545$2.98$7.6K

View →

Nov 18, 2025Nov 18 8:26 PMShah Gaurav
Proposed Sale
6,276$2.98$18.7K

View →

Nov 18, 2025Nov 18 8:16 PMMilitello John
Proposed Sale
1,086$2.98$3.2K

View →

Nov 18, 2025Nov 18 8:16 PMWilson Martin
Proposed Sale
1,646$2.98$4.9K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 3, 2026Aug 6 12:49 AMChristopher James StevensChief Operating Officer
Grant/Award
101,428$3.41101,428(D)

View →

Jun 18, 2026Jul 7 12:00 AMRoderick WongDirector, 10% Owner
Grant/Award
78,960$3.3578,960(D)

View →

Jun 18, 2026Jul 7 12:00 AMPeter FongDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMMikael DolstenDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMFady Ibraham MalikDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMDavid P SouthwellDirector
Grant/Award
64,860$3.3564,860(D)

View →

Jun 18, 2026Jul 6 11:59 PMCarsten BoessDirector
Grant/Award
64,860$3.3564,860(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Disposition
238,256$62.320(D)

View →

May 26, 2026May 28 8:33 PMJohn MilitelloVice President of Finance, Treasurer, Principal Accounting Officer
Grant/Award
116,562$3.009,091(D)

View →

May 21, 2026May 26 11:47 PMGaurav ShahCEO
Option Exercise
76,490$1.690(D)

View →

Feb 11, 2026Feb 13 9:05 PMGaurav ShahCEO
Grant/Award
870,648$3.24870,648(D)

View →

Feb 11, 2026Feb 13 9:05 PMJohn MilitelloOfficer
Grant/Award
45,018$3.2445,018(D)

View →

Feb 11, 2026Feb 13 9:05 PMMartin WilsonGeneral Counsel
Grant/Award
468,187$3.24468,187(D)

View →

Feb 11, 2026Feb 13 9:05 PMSyed Ali-Aamir RizviChief Medical Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMChristopher James StevensChief Operating Officer
Grant/Award
93,037$3.2493,037(D)

View →

Feb 11, 2026Feb 13 9:05 PMSarbani ChaudhuriChief Commercial & Medical Affairs Officer
Grant/Award
189,076$3.24189,076(D)

View →